Johnson & Johnson Q4 Profit Decreases, But Beats Estimates
Johnson & Johnson (JNJ) announced a profit for fourth quarter that decreased from last year but beat the Street estimates. The ...
These Stocks Are Moving the Most Today: Netflix, Oracle, Nvidia, United Airlines, Agilysys, J&J, and More
Netflix stock soars after strong subscriber gains, and Oracle teams with OpenAI and SoftBank in a $500 billion AI ...
J&J's earnings beat estimates but guidance is mixed
Johnson & Johnson's stock (JNJ) rose 1.9% early Wednesday, after the medical tech and drug company posted better-than-expected earnings for the fourth quarter, offsetting mixed guidance. The company ...
Johnson & Johnson Beats Earnings Estimates and Forecasts 2025 Growth
Johnson & Johnson’s latest earnings bested Wall Street estimates, as the company braces for one of its top-selling medicines ...
J&J Reports Strong Revenue and Profit But Faces Challenges in 2025
Johnson & Johnson reported better-than-expected quarterly revenue and profit on higher sales of cancer drugs and some medical devices. Yet the healthcare company faces headwinds in 2025—including a ...